Crestor Indication Grows User Pool, But Self-Selection Hinders Statin Switch
This article was originally published in The Tan Sheet
Executive Summary
Switching statins OTC will require comprehensive consumer education to enable self-selection and flexibility from FDA on the types of information it considers product labeling
You may also be interested in...
Self-Selection Studies Need Room To Evaluate Purchase Decisions - Expert
The division between product selection and purchase decisions is not as distinct as FDA suggests in the recent draft guidance on designing self-selection studies to support Rx-to-OTC switches, PEGUS Research's McCammon says
Self-Selection Studies Need Room To Evaluate Purchase Decisions - Expert
The division between product selection and purchase decisions is not as distinct as FDA suggests in the recent draft guidance on designing self-selection studies to support Rx-to-OTC switches, PEGUS Research's McCammon says
Self-Selection Studies Need Room To Evaluate Purchase Decisions – Expert
FDA should allow researchers more flexibility to evaluate consumers’ purchase decisions in self-selection studies for OTC drugs, according to contract research organization PEGUS Research.